4.7 Article

Lysophosphatidic acid-activated Cl- current activity in human systemic sclerosis skin fibroblasts

Journal

RHEUMATOLOGY
Volume 49, Issue 12, Pages 2290-2297

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/keq260

Keywords

Cl- channel; Lysophosphatidic acid; alpha-Smooth muscle actin; Myofibroblast; Fibroblast

Categories

Funding

  1. National Scleroderma Foundation
  2. University of Tennessee Rheumatic Disease Core Center
  3. NCI [CA92160]
  4. NIAMS Scleroderma SCOR [P50AR044890]
  5. Department of Veterans Affairs
  6. Grants-in-Aid for Scientific Research [22790203] Funding Source: KAKEN

Ask authors/readers for more resources

Methods. Skin biopsies were taken from involved and uninvolved skin of SSc patients and controls. Whole-cell perforated patch-clamping was used to measure IClLPA activity in fibroblasts isolated and cultured from these biopsies. Western blotting was used to measure alpha-smooth muscle actin (alpha-SMA). Proliferation was measured using a colorimetric assay. Results. Fibroblasts cultured from SSc skin show significantly increased IClLPA activity following LPA exposure compared with control skin fibroblasts. alpha-SMA protein was significantly increased in cultured SSc skin fibroblasts vs controls. No significant differences in proliferation rates were found. Conclusions. Elevated IClLPA activity is a hallmark of SSc skin fibroblasts. Blocking IClLPA activation may be a new therapeutic approach for treating SSc-associated fibrosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available